Digest Network Come funziona
Network
/
Società
AS
Società

ASABYS

Di cosa scriviamo

Auto/AutomotiveIngegneriaSaluteSanitàUniversità

35 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
02/09/2026
Salute
Oncologia
Sanità
iPremom raises €15m to transform pregnancy care with molecular diagnostics - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
11/06/2026
Salute
Sanità
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
04/06/2026
Salute
Oncologia
Sanità
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
20/05/2026
Salute
Giochi
Auto/Automotive
Asabys Announces a New Life Sciences Fund Following Its Selection in the CDTI and EIF Innvierte Deep Start Initiative - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
19/05/2026
Economia
Economia internazionale
Salute
Giochi
The Ministry of Science, Innovation and Universities, through CDTI, and the EIF invest €74.7 million in the Asabys Innvierte Tech Transfer fund to boost innovation and company creation in biotechnology and medical technologies - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
25/02/2026
Università
Salute
Sanità
Medasense Appoints MedTech Leader Peter Wehrly as Executive Chairman of the Board - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
03/02/2026
Salute
Sanità
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
22/01/2026
Salute
Sanità
Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
13/01/2026
Salute
Sanità
SafeHeal® Announces Successful Launch of SAFE-3CV IDE Study for Colovac® Anastomosis Protection Technology - Asabys Partners
Fonte
ASABYS
1.00
0
Press Release cover image
09/01/2026
Salute
Sanità
Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort - Asabys Partners
Fonte
ASABYS
1.00
0

Recapiti

ASABYS

PASSEIG DE GRÀCIA 53, ÀTIC Barcelona 08007 08007 Barcelona
626 119 459

Social Media

Seguaci
0
Compatibilità
0